全球临床前抗菌管道的多年分析:趋势和差距
Valeria Gigante1, Richard A Alm2,3, Daniela Melchiorri4
1AMR Division, World Health Organization, Geneva, Switzerland.
Antimicrobial agents and chemotherapy
|July 15, 2024
概括
抗菌素耐药性 (AMR) 是一个日益严重的全球危机. 本次审查审查了早期抗生素开发阶段,以确定新抗菌药物的差距和机会.
科学领域:
- 全球健康 全球健康
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗菌素耐药性 (AMR) 构成了全球健康的重大威胁,在2019年造成超过127万人死亡,并影响全球经济.
- 抗菌药物耐药性日益增长的患病率有可能进入后抗生素时代,危及常见细菌感染的治疗.
- 持续供应新型抗菌药物对于对抗不断演变的耐药性模式至关重要.
研究的目的:
- 评估前临床和临床抗菌药物开发管道的状态.
- 确定抗生素研发人员在抗生素研发的早期阶段所面临的挑战.
- 探索潜在的新型抗生素类别和针对耐药细菌的新型作用机制.
主要方法:
- 审查世界卫生组织对抗菌药物开发管道的评估.
- 对临床前抗生素开发趋势的分析.
- 识别早期抗菌药物研发中的差距和机遇.
主要成果:
- 目前新型抗菌剂的管道中存在差距.
- 显著的挑战阻碍了抗生素药物开发的早期阶段.
- 审查强调了需要采取主动策略来应对不断变化的耐药性.
结论:
- 对抗菌药物发现的持续创新对于减轻抗菌耐药性威胁至关重要.
- 解决早期发展阶段的障碍对于新抗生素的可持续管道至关重要.
- 了解发展趋势是确保未来抗药性感染治疗选择的关键.
相关概念视频
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Antibiotic Selection
53.0K
Overview
53.0K
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K


